Related Experiment Video
Updated: Nov 13, 2025
Author Spotlight: Advancing Corneal Innervation Research Through Innovative Models
Published on: December 8, 2023
Neurotrophic keratitis after penetrating keratoplasty for lattice dystrophy
Larissa Gouvea1, Raphael Penatti2, Karolinne Maia Rocha1
1Storm Eye Institute, Medical University of South Carolina, Charleston, SC, USA.
Purpose:
To report clinical outcomes of a patient with unilateral neurotrophic keratitis following penetrating keratoplasty for lattice dystrophy treated with topical recombinant human nerve growth factor.
Observations:
A 75-year-old male with lattice dystrophy and history of herpes simplex keratitis, presented with recurrent neurotrophic ulceration in the right eye two years following penetrating keratoplasty. The patient was successfully treated with topical recombinant human nerve growth factor.
Conclusion:
Neurotrophic keratitis is a rare chronic disorder that affects quality of life due to the risk of vision loss. Topical recombinant human nerve growth factor is a novel and effective treatment option that may help improve optical quality and patient's satisfaction as shown in this case of recurrent neurotrophic keratitis.
